Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chi-Un Pae. (2013) Role of the cholinesterase inhibitors in the treatment of schizophrenia. Expert Opinion on Investigational Drugs 22:3, pages 293-298.
Read now
Read now
Maurizio Coppola & Raffaella Mondola. (2012) Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: A review. Nordic Journal of Psychiatry 66:2, pages 73-78.
Read now
Read now
Articles from other publishers (31)
Vladimir P. Grinevich, Amir N. Zakirov, Uliana V. Berseneva, Elena V. Gerasimova, Raul R. Gainetdinov & Evgeny A. Budygin. (2022) Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders. Cells 11:9, pages 1533.
Crossref
Crossref
Yash B. Joshi. 2023. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework
393
406
.
Rafaella Georgiou, Demetris Lamnisos & Konstantinos Giannakou. (2021) Anticholinergic Burden and Cognitive Performance in Patients With Schizophrenia: A Systematic Literature Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Hemen S. Ved & Gaurav M. Doshi. (2020) A Review on Emerging Drug Targets in Treatment of Schizophrenia. Current Drug Targets 21:15, pages 1593-1605.
Crossref
Crossref
Xicheng Yang, Jian Shen, Lulu Jiang, Wei Li, Mingcheng Yu, Guanxing Pan, Yurong Yan, Chenghan Zhang, Wanwan Jia, Li Xiao, Haihua Yu, Hao Chen, Yilin Zheng, Linqian Yu, Qiong Xie, Lu Zhou & Liming Shao. (2018) Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities. European Journal of Medicinal Chemistry 160, pages 37-48.
Crossref
Crossref
Lara M. Gomes, Giselli Scaini, Milena Carvalho-Silva, Maria L. Gomes, Fernanda Malgarin, Luiza W. Kist, Maurício R. Bogo, Eduardo Pacheco Rico, Alexandra I. Zugno, Pedro F. P. Deroza, Gislaine Z. Réus, Airam B. de Moura, João Quevedo, Gustavo C. Ferreira, Patrícia F. Schuck & Emilio L. Streck. (2018) Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats. Neurotoxicity Research 34:4, pages 769-780.
Crossref
Crossref
Samantha E. Yohn & P. Jeffrey Conn. (2018) Positive allosteric modulation of M 1 and M 4 muscarinic receptors as potential therapeutic treatments for schizophrenia. Neuropharmacology 136, pages 438-448.
Crossref
Crossref
O. J. Onaolapo, T. B. Paul & A. Y. Onaolapo. (2017) Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours. Metabolic Brain Disease 32:5, pages 1475-1489.
Crossref
Crossref
Albert Yang & Shih-Jen Tsai. (2017) New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis. International Journal of Molecular Sciences 18:8, pages 1689.
Crossref
Crossref
Adejoke Y. Onaolapo, Olufemi A. Aina & Olakunle James Onaolapo. (2017) Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia. Biomedicine & Pharmacotherapy 92, pages 373-383.
Crossref
Crossref
Jian Shen, Xi-cheng Yang, Ming-cheng Yu, Li Xiao, Xun-jie Zhang, Hui-jiao Sun, Hao Chen, Guan-xin Pan, Yu-rong Yan, Si-chen Wang, Wei Li, Lu Zhou, Qiong Xie, Lin-qian Yu, Yong-hui Wang & Li-ming Shao. (2016) Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands. Acta Pharmacologica Sinica 38:1, pages 146-155.
Crossref
Crossref
A Ghoshal, J M Rook, J W Dickerson, G N Roop, R D Morrison, N Jalan-Sakrikar, A Lamsal, M J Noetzel, M S Poslusney, M R Wood, B J Melancon, S R Stauffer, Z Xiang, J S Daniels, C M Niswender, C K Jones, C W Lindsley & P J Conn. (2015) Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Neuropsychopharmacology 41:2, pages 598-610.
Crossref
Crossref
Maurizio Coppola, Raffaella Mondola, Francesco Oliva & Rocco Luigi Picci. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
794
802
.
Tanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, Thilo Kellermann, Michael Paulzen, Paul Cumming & Gerhard Gründer. (2014) Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers. Psychopharmacology 232:9, pages 1607-1617.
Crossref
Crossref
Katrina Weston-Green, Xu-Feng Huang & Chao Deng. (2013) Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor. CNS Drugs 27:12, pages 1069-1080.
Crossref
Crossref
Roger B. Varela, Samira S. Valvassori, Jéssica Lopes-Borges, Daiane B. Fraga, Wilson R. Resende, Camila O. Arent, Alexandra I. Zugno & João Quevedo. (2013) Evaluation of acetylcholinesterase in an animal model of mania induced by d-amphetamine. Psychiatry Research 209:2, pages 229-234.
Crossref
Crossref
Jared W. Young, Jessica M. Meves & Mark A. Geyer. (2013) Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. Behavioural Brain Research 240, pages 119-133.
Crossref
Crossref
Anish Khan, Aftab Aslam Parwaz Khan, Abdullah M. Asiri, Malik Abdul Rub, Naved Azum, Mohammed M. Rahman, Sher Bahadar Khan & Sulaiman Ab Ghani. (2013) A New Trend on Biosensor for Neurotransmitter Choline/Acetylcholine—an Overview. Applied Biochemistry and Biotechnology 169:6, pages 1927-1939.
Crossref
Crossref
Lezio Soares Bueno-Junior, Cleiton Lopes-Aguiar, Rafael Naime Ruggiero, Rodrigo Neves Romcy-Pereira & João Pereira Leite. (2012) Muscarinic and Nicotinic Modulation of Thalamo-Prefrontal Cortex Synaptic Pasticity In Vivo. PLoS ONE 7:10, pages e47484.
Crossref
Crossref
Eric Y. H. Chen & Christy L. M. Hui. (2012) HT1001, A Proprietary North American Ginseng Extract, Improves Working Memory in Schizophrenia: A Double-blind, Placebo-Controlled Study. Phytotherapy Research 26:8, pages 1166-1172.
Crossref
Crossref
Rafael Stryjer, Dana Ophir, Faina Bar, Baruch Spivak, Abraham Weizman & Rael D. Strous. (2012) Rivastigmine Treatment for the Prevention of Electroconvulsive Therapy–Induced Memory Deficits in Patients With Schizophrenia. Clinical Neuropharmacology 35:4, pages 161-164.
Crossref
Crossref
Bianca Voss, Renate Thienel, Martina Reske, Thilo Kellermann, Abigail J. Sheldrick, Sarah Halfter, Katrin Radenbach, Nadim J. Shah, Ute Habel & Tilo T. J. Kircher. (2011) Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects. European Archives of Psychiatry and Clinical Neuroscience 262:4, pages 329-339.
Crossref
Crossref
Elizabeth Scarr. (2011) Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets. CNS Neuroscience & Therapeutics 18:5, pages 369-379.
Crossref
Crossref
Elizabeth Scarr & Brian Dean. (2012) Altered Neuronal Markers Following Treatment with Mood Stabilizer and Antipsychotic Drugs Indicate an Increased Likelihood of Neurotransmitter Release. Clinical Psychopharmacology and Neuroscience 10:1, pages 25-33.
Crossref
Crossref
Lucinda J. Steward, Matthew D. Kennedy, Brian J. Morris & Judith A. Pratt. (2012) Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain : Impact of antipsychotic drug treatment. Neuropharmacology 62:3, pages 1554-1563.
Crossref
Crossref
Francesco Papaleo, Barbara K. Lipska & Daniel R. Weinberger. (2012) Mouse models of genetic effects on cognition: Relevance to schizophrenia. Neuropharmacology 62:3, pages 1204-1220.
Crossref
Crossref
Susan J. Bartko, Carola Romberg, Benjamin White, Jürgen Wess, Timothy J. Bussey & Lisa M. Saksida. (2011) Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method. Neuropharmacology 61:8, pages 1366-1378.
Crossref
Crossref
Ting-Gang Chang, Wen-Yu Hsu, Yen-Kuang Yang & Jui-Ting Liu. (2014) ‘Pseudo-paraplegia': a chronic psychotic sequela of organophosphate exposure in schizophrenia. Acta Neuropsychiatrica 23:5, pages 257-258.
Crossref
Crossref
Susan J. Bartko, Ignasi Vendrell, Lisa M. Saksida & Timothy J. Bussey. (2010) A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Psychopharmacology 214:2, pages 537-548.
Crossref
Crossref
Yukio Ago, Ken Koda, Kazuhiro Takuma & Toshio Matsuda. (2011) Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine. Journal of Pharmacological Sciences 116:1, pages 6-17.
Crossref
Crossref
Paul A Garris. (2010) Advancing neurochemical monitoring. Nature Methods 7:2, pages 106-108.
Crossref
Crossref